Sensus Healthcare (SRTS) Projected to Post Earnings on Wednesday

Sensus Healthcare (NASDAQ:SRTS) is expected to be releasing its earnings data after the market closes on Wednesday, February 5th. Analysts expect Sensus Healthcare to post earnings of $0.10 per share and revenue of $10.31 million for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Sensus Healthcare Stock Up 1.9 %

Sensus Healthcare stock opened at $6.92 on Wednesday. The company has a market capitalization of $113.42 million, a PE ratio of 12.14 and a beta of 1.21. Sensus Healthcare has a 12-month low of $2.91 and a 12-month high of $9.33. The firm’s fifty day moving average is $7.62 and its 200 day moving average is $6.81.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. HC Wainwright upped their price objective on shares of Sensus Healthcare from $10.00 to $11.00 and gave the company a “buy” rating in a report on Monday, November 18th. Maxim Group upped their price target on Sensus Healthcare from $12.00 to $14.00 and gave the stock a “buy” rating in a research note on Friday, November 15th.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.